Valeant, now Bausch Health, paid $1 billon in 2015 for Sprout Pharmaceuticals’ female libido drug Addyi, only to sell it back in 2017. Now as the drug is still nowhere near the blockbuster status ...
In a little noticed move, the company that sells the Addyi pill for female sexual dysfunction recently won regulatory approval in Canada, thanks to a followup study designed to address a nagging ...
Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? The "little pink pill" is now available to even more women. The Food and Drug ...
Valeant Pharmaceuticals International added 250 primary-care sales reps to its Salix sales force, which markets therapies like irritable-bowel-syndrome drug Xifaxan and opioid-induced constipation ...
WILMINGTON, Del. (Reuters) - Valeant Pharmaceuticals International Inc was sued on behalf of former investors in Sprout Pharmaceuticals Inc, which it bought last year for $1 billion, over its alleged ...
Health and Me on MSN
Addyi: FDA approves libido-boosting drug for postmenopausal women – what does it mean for women’s sexual health?
The FDA has expanded approval of Addyi, a once-daily libido drug, allowing postmenopausal women over 65 to use it. The decision revives debate around hypoactive sexual desire disorder, the drug’s side ...
Raleigh, N.C. - September 21, 2015 - Sprout Pharmaceuticals, Inc. (Sprout) announced today that healthcare prescribers and pharmacies can now complete training to become certified to prescribe or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback